27 studies found for:
" December 14, 2011":" January 13, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
|
||||
| 2 | Active, not recruiting |
Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen in HIV 1 Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 3 | Recruiting |
Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
|
||||
| 4 | Completed |
Couple-oriented Prenatal HIV Counseling in Low and Medium HIV Prevalence Countries
|
||||
| 5 | Recruiting |
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
|
||||
| 6 | Active, not recruiting |
Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers
|
||||
| 7 | Recruiting |
Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
|
||||
| 8 | Recruiting |
Impact of Immediate Versus WHO Recommendations Guided ART Initiation on HIV Incidence - Feasibility Phase
|
||||
| 9 | Recruiting |
Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men and in At-Risk Women
|
||||
| 10 | Completed |
Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
|
||||
| 11 | Recruiting |
Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression
|
||||
| 12 | Not yet recruiting |
Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
|
||||
| 13 | Recruiting |
Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
|
||||
| 14 | Completed |
Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults
|
||||
| 15 | Completed |
Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol
|
||||
| 16 | Active, not recruiting |
A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects
|
||||
| 17 | Recruiting |
American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial
|
||||
| 18 | Not yet recruiting |
Randomized Controlled Trial Using Patient Reported Outcomes and Care Managers to Improve HIV Medication Adherence in Routine Clinical Care
|
||||
| 19 | Not yet recruiting |
Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
|
||||
| 20 | Recruiting |
Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
|
† Indicates status has not been verified in more than two years
